Oocytes accumulate mRNAs in the form of maternal ribonucleoprotein (RNP) particles, the protein components of which determine the location and stability of individual mRNAs prior to translation. Scd6 proteins, typified by RAP55, functions in a wide range of eukaryotes in repressing translation and relocating mRNPs to processing bodies and stress granules. Here we describe in Xenopus laevis a variant of RAP55, xRAPB, a member of the LSM14B family of proteins found in many other organisms, which also contains conserved Lsm and FDF domains but differs in containing fewer RGG repeats. xRAPB differs from xRAPA in other respects: it is expressed at high concentration earlier in oogenesis; it interacts specifically with the RNA helicase Xp54; it is a component of mRNP particles with a different size distribution; its over-expression leads to selective binding to translatable mRNA species without evidence of translation repression or mRNA degration. Since Xp54 is a dominant repressor of translation, activation appears to be effected by the dislocation of Xp54 from xRAPB.
Introduction
Throughout its existence, mRNA is associated with a wide range of proteins that determine its history and fate: co-transcriptional processing, nucleocytoplasmic transport, cellular localization and ability to be translated, result from a succession of interactions with protein factors and microRNAs (Muller-McNicoll and Neugebauer, 2013) . Although many RNA sequence-and structure-specific proteins have been identified, little is known of the extent of heterogeneity in protein composition across the range of mRNP particles. In developing organisms, substantial amounts of mRNP are formed and stored until required for the synthesis of stage-specific proteins, whereas other mRNPs undergo immediate translation to establish the metabolic machinery (Lai and King, 2013) . Not only the timing of translation initiation is determined but also the cessation of translation and mRNA decay. These and more subtle effects on the regulation of translation are incurred through the remodelling of mRNP particles. Key processes include: addition and removal of translation masking proteins, cytoplasmic regulation of poly(A) tail length, binding of translation initiation factors to the 5' cap structure, interaction of proteins bridging the 3' and 5' ends of the mRNA, mRNA localization, decapping and hydrolysis of the mRNA (Balagopal and Parker, 2009) .
A paradigm for these various effects has been established from studies on oogenesis and early development of Xenopus laevis. Over a period of months, oocytes accumulate large numbers of non-translating, maternal mRNA molecules (>10 11 / oocyte) that are stored to be mobilized to polysomes during later stages of oogenesis, oocyte maturation and, after fertilization, early embryogenesis. During their storage phase, most of these mRNAs have relatively short poly(A) tails (10-30 residues) at their 3' termini (Cabada et al., 1977) . Several abundant proteins are found to be associated with these maternal mRNAs to form large RNA-protein complexes which mostly sediment at 30-80 S and have a buoyant density in CsCl of 1.36 g.cm -3 (equivalent to a protein:RNA mass ratio of 4:1).
The four most abundant proteins have apparent (electrophoresis) molecular masses between 50-60 kDa (Darnbrough and Ford, 1981) : the two slowest migrating were identified as cold-shock domain Y-box proteins, FRGY2a/b (YB2: Deschamps et al., 1992; Murray et al.,1992) and the next as the DEAD-box RNA helicase Xp54/Dhh1 (Ladomery et al., 1997) . The fourth protein, of 52 kDa, described in this report as xRAPB, is identified as a variant of RAP55 which is expressed in a wide range of organisms (Marnef et al., 2009) . RAP55 was first identified as an RNA-associated protein expressed in oocytes of the amphibian Pleurodeles waltl (Lieb et al. 1998 ). Its orthologue is also expressed in Xenopus oocytes and is here referred to as xRAPA. All of the RAP55 proteins, including xRAPA and xRAPB, belong to the Scd6 family (Anantharaman and Aravind, 2004) , characterized by a multidomain organization consisting of a conserved N-terminal Lsm domain and varied central and C-terminal regions defined by an FDF domain and RGG repeats (Albrecht and Lengauer, 2004) .
In this report we examine to what extent structural differences between xRAPA and xRAPB are reflected in differences in function.
RAP55/xRAPA has been shown to act as a translation repressor (Tanaka et al., 2006) , as have the core mRNP proteins, YB2a/b (Kick et al.,1987 : Matsumoto et al., 1996 Yurkova and Murray, 1997; Sommerville, 1999) and Xp54 (Minshall and Standart, 2004: Minshall et al., 2009) , along with other mRNP proteins: CPEB (Minshall et al., 2007) , 4-ET (Minshall et al., 2007) and P100/Pat1 (Marnef et al., 2010 : Nakamura et al., 2010 . However, other proteins, involved in mRNP trafficking and translation activation during oogenesis, have yet to be identified. Here we describe several features of xRAPB, which distinguish it from RAP55/xRAPA, specifically in having a key role in the regulation of mRNA metabolism during the early stages of oocyte development.
Materials and methods

Sequencing and cloning
Sequence information for Xenopus laevis xRAPA was obtained originally from EST clones BG408666 and BG486665 (European Bioinformatics Institute: www.ebi.ac.uk) which showed 74% protein identity with RAP55 of Pleurodeles waltii (UNIPROT Q9YH12; www.uniprot.org ; Lieb et al., 1998) and were known to be expressed in oocytes of X. laevis. A complete coding sequence was constructed from PCR reactions and later found to be identical at the protein level to that of IMAGE clone 3405473 (I.M.A.G.E Consortium: www.imageconsortium.org).
xRAPB was initially detected by peptide sequencing of an mRNP protein of 52 kDa isolated from stage I oocytes of X. laevis: one of the peptide sequences, M/VEQAV, did not occur in either RAP55 or xRAPA, but was later detected in a human clone (UNIPROT Q9BX40) which showed 45% identity with RAP55. X. laevis EST clones BI444610 and BG731378 were used to generate more extensive and overlapping sequences which were found to form a complete 5' insert in IMAGE clone 3473035 and a complete 3' insert in IMAGE clone 4674033, with a 299 bp overlap between them.
Expression vectors
PCR copies from cDNA clones encoding complete sequences of xRAPA and xRAPB were inserted into the pCS2*mt-SGP vector between the unique Eco RI site immediately downstream of the 6-times myc epitope and the Xba I site immediately upstream of the in-frame GFP sequence as described previously (Smillie and Sommerville, 2002) . Stop codons were retained, or inserted, in a second set of vectors to generate transcripts lacking part or all of the GFP sequence. The pCGT vector expressing the complete sequences of Xp54 following a leader sequence encoding a T-epitope has been described (Smillie and Sommerville, 2002) . All in vivo expression was driven from the CMV promoter. For in vitro expression, proteins were generated using the T N T Quick Coupled Transcription/Translation System (Promega, Madison, WI) according to the supplier's instructions. Briefly, 0.5-2 g of plasmid DNA was used in combination with 20 Ci of [
35 S]-methionine (Redivue >1000 Ci/mmole; Amersham Biotech. GE Healthcare) and either T7 or SP6 RNA polymerase (Promega). After incubation at 30 o C for 90 min., the reactions were filtered through Sephadex G-50 (GE Healthcare) by centifugation in micro-pipette tips to separate the products from unincorporated radioactivity and small molecules. The integrity of radiolabelled products was checked by SDS-PAGE/autoradiography. Quantitation of incorporation was calculated by sampling aliquots in duplicate on to GF/A glass fibre filters (Whatman, GE Healthcare), with and without TCA precipitation and followed by scintillation counting according to supplier's instructions (Promega).
Morpholinos
Antisense morpholinos (Gene Tools, Philomath, OR) were directed against RNA sequences adjacent to translation start site (bold, where included):
Xp54 mRNA 3'TACTCGTGGCGGTCTTGTCTCTTGG 5'
All injected antisense morpholinos showed specific down-regulation of both endogenous and recombinant forms of the target proteins. No deleterious effect on oocytes were observed.
Oocyte isolation and extraction
Ovary was excised from immature X. laevis and oocytes were released and maintained in OR-2 medium and sorted into individual stages as described in detail (Sommerville, 2010) . Pools of ~1000, 400, 100 and 40 oocytes, of stages I, II, III and IV were homogenized in HB: 0.1 M NaCl; 2 mM MgCl 2 ; 2 mM dithiothreitol, 20mM
Tris-HCl, pH 7.5. Yolk and lipid were extracted with 1,1,2-trichlorotrifluoroethane (Evans and Kay, 1991) . After centrifugation at 10,000 rpm for 15 min at 0 o C in a Sorvall SS-34 rotor, the clarified supernatant (SN10) was carefully removed. The extracts were maintained at <2 o (Promega) and where appropriate 5 mM EDTA (Sigma). Poly(A + ) RNP was bound to and eluted from oligo(dT) cellulose (Type 7; Pharmacia, GE Healthcare) as described previously (Ladomery et al., 1997) . Typical recovery of poly(A + ) RNP from early stage oocytes was 250-350 g/ml eluate.
Primary antibodies
Poly(A) + RNP from early (stage I) oocytes was separated into a heat stable supernatant containing YB2a/b (Deschamps et al., 1992 ) and a heat-labile precipitate containing principally Xp54 and xRAPB. Antibodies were raised against the renatured proteins from these two fractions. Rabbits producing anti-YB2 generally gave equal reactivity to the a and b forms. Rabbits producing antibodies to the heat-labile proteins gave variable immuno-reactivities, either against Xp54 or xRAPB.
Antibodies specific for Xp54 and p52 (xRAPB) were raised against gel-isolated proteins which were renatured by staged dilution from 8M urea into HB (Ladomery et al., 1997; Sommerville and Ladomery, 1996) . Rabbit anti-ERK2 was obtained from 
Oocyte injection and radiolabelling
Stage IV oocytes from albino females were randomly distributed into four sets of 40-50 oocytes and each set was colour-coded using vital stains as described (Sommerville, 2010) . 
Immunoblotting
Proteins, equivalent to one oocyte, were separated by SDS-PAGE, transferred to nitrocellulose (0.45 micron, Pierce Biotech. Thermo Fisher) and immunoblotted as described previously (Ryan et al., 1999) . Primary antisera or IgG were used at 1:5,000 
Immunoprecipitation
Antibodies were linked to ProSep-vA beads (Millipore, Watford, UK) and proteins or mRNP bound from HB containing 0.05% NP-40 (Sigma) and released as described previously (Ryan et al., 1999) .
UV crosslinking
Samples of poly(A) + RNP (25-35 g in 100 l HB) were placed in a silicone-treated glass depression tray seated on ice and irradiated with 254-nm light at 6,000 W/cm 2 for 5 min to establish protein-RNA crosslinks or 30 min to produce (more extensive)
protein-protein crosslinks. Half of irradiated samples were treated with 1 mg/ml ribonuclease A at 37 o C for 30 min to resolve close protein-protein association.
Rate sedimentation analysis
Clarified oocyte extracts and poly(A + ) fractions were layered on 10-25% glycerol gradients made up in: 0.1 M NaCl; 2 mM MgCl 2 ; 2 mM dithiothreitol; 20 mM TrisHCl, pH 7.5 plus 0.05% NP-40, g/ml cycloheximide. For ribosome dissociation, MgCl 2 was replaced with 5 mM EDTA.
After centrifugation at 36,000 rpm in a 6 x 5 ml swing-out rotor (Beckman SW50Ti) at 0 o C for 2-3 hours, the tube contents were fractionated. Fractions were analysed for proteins by immunoblotting. Sedimentation rates were calculated using 80S ribosomes and 60S and 40S ribosomal subunits run in parallel gradients and scanned through a flow cell measuring absorbance at 254 nm.
Density gradient centrifugation
Unfixed poly ( 
RNA extraction, hybridization and RT-PCR
RNA was isolated extracts of 25 oocytes or acetone-or ethanol-precipitated gradient fractions or from immunoprecipitates raised in 250 g HB plus RNasin and from their supernatants, by addition of SDS to 1% followed by extractions with equal volumes of phenol-chloroform-isoamyl alcohol then chloformisoamyl alcohol. 1/10 th volume of 5M sodium acetate and 20 g transfer RNA (Sigma) were added to the extracts and RNA was ethanol precipitated. Dried pellets were raised in RNase-free H 2 O. RNA for hybridization analysis was either separated by gel electophoresis and transferred to nylon membranes or applied directly to the membranes using a Hybri-Slot Manifold (BRL, Bethesda) and hybridized with 32 [P]-CTP labelled antisense probes essentially as described (Sheets et al., 2010) . RNA as a template for two-stage RT-PCR was used with random hexamers in the ImProm-II TM Reverse Transcription System (Promega) to generate cDNA followed by amplification with GoTaq TM Master Mix (Promega) as specified by the manufacturer.
Gene-specific primer pairs were used to generate products of 300-400 bp after 28 cycles. Products were analysed by electrophoresis on agarose gels as described (Huber and Zhao, 2010) .
Gene specific primer pairs: 
Results
Identification and expression of xRAPB
The original guinea pig antibody raised against recombinant RAP55 recognized three proteins in oocyte extracts from Pleurodeles waltl with apparent masses of 140, 68 and 56 kDa, but only one protein from Xenopus laevis with a mass of 52 kDa (Lieb et al., 1998) . The 68 kDa protein was named RNA-associated protein 55 (the predicted mass of the sequenced clone being 55 kDa). The rabbit antibody raised against a 52 kDa protein isolated from Xenopus mRNP (Sommerville and Ladomery 1996) recognizes only the 52 kDa protein from Xenopus and the 56 kDa protein from Pleurodeles ( Fig. 1A) . Subsequent cDNA cloning, based on peptide analysis of the 52 kDa protein, eventually identified it as a shorter variant of RAP55, one which we named RapB/xRAPB (Weston and Sommerville, 2006; Marnef et al., 2009) . The relationships between these proteins, including a form identical to xRAPB but with a single internal deletion (xRAP42; Arthur et al., 2009) , are indicated (Fig. 1B) .
Immunoblotting of extracts from developing oocytes using anti-p52/anti-xRAPB shows highest reactivity with early stages (I-II), with decreasing signal as oogenesis proceeds (Fig. 1C, top panel) . Quantitation of the encoding mRNA/oocyte mass by RT-PCR reveals a similar pattern (Fig. 1C, bottom panel) . However, on a per oocyte basis, the amount of xRAPB-encoding mRNA increases through oogenesis, indicating that expression of xRAPB, itself, is subject to translational control.
Immunostaining of ovary sections with anti-xRAPB reflects the immunoblotting results, with reaction steadily decreasing from early stage to be low in concentration by late stage (Fig. 1D ). It is also apparent that the cognate protein is almost exclusively cytoplasmic, as has been shown for RAP55/xRAPA (Tanaka et al., 2006) .
Immunoblotting of oocyte fractions bound or unbound by oligo(dT)-cellulose
shows that the protein detected by anti-xRAPB is bound to an extent similar to bona fide mRNP components, such as Xp54, YB2 and CPEB (Fig. 1E) . Binding efficiency is similar in the presence of either Mg 2+ or EDTA, conditions which may influence intermolecular associations. Xp54, YB2 and xRAPB continue to be present in the poly(A) + fractions after progesterone-induced maturation, but at lower levels.
Immunoreaction with anti-ERK2 is shown as a non-mRNP control and with antipMAPK as an oocyte maturation marker.
All indications are that xRAPB is an integral component of mRNP particles, particularly of a major population present in early oocytes. That xRAPB is a stablybound component of these particles can be shown by equilibrium gradient centrifugation of unfixed poly(A) + RNP through high salt (15-40% Cs 2 SO 4 ).
Immunoblotting of gradient fractions with a mixture of antibodies to recognize the major mRNP proteins shows that xRAPB together with Xp54 remain bound to RNA (at a buoyant density of 1.44 g.cm 3 ) after much of the YB2 has been stripped off and recovered at around 1.22 g.cm 3 (Fig.1F) . That the density peak represents the core of mRNP particles is demonstrated by extraction of RNA from the gradient fractions and hybridization with labelled probes directed against a range of early-expressed mRNAs, panels of two of which, nucleolin and histone deacetylase (HDACm) are shown (Fig. 1F) . Thus the vast majority of hybridization signal corresponds to the position of the xRAPB immunostaining signal. For comparison, particles containing all of the major mRNP proteins can be obtained within a single density peak at around 1.39 g.cm 3 on banding in CsCl gradients (Fig. 1F ). This density in CsCl corresponds to a protein:RNA ratio approaching the value of 4:1 which is normally quoted for intact mRNP (Cummings and Sommerville, 1988) . The differential removal of YB2, especially of YB2b, from mRNP in moderate salt conditions (1 M NaCl) has already been noted (Ladomery and Sommerville, 1996) and may help explain better retention of YB2 in CsCl than in Cs 2 SO 4 .
Comparison of interactions of xRAPA and xRAPB with Xp54
Previous results have indicated a direct interaction of xRAPB with Xp54 helicase, an interaction that is not evidenced in early-stage oocytes with xRAPA (Minshall et al. 2007 ). Here we extend these observations by examining protein-protein interactions that occur using in vitro synthesised xRAPA, xRAPB and Xp54 ( Fig. 2A) and compare the results with those obtained through crosslinking of proteins within native RNP particles.
Interaction of xRAPB with Xp54 can be shown by reciprocal immunoprecipitation from combinations of the in vitro-synthesized proteins. Incubation of xRAPB with Xp54 and xRAPA with Xp54 was followed by binding and elution from immobilized anti-Xp54 and anti-xRAPB. Autoradiographs show that anti-Xp54 co-precipitates xRAPB much more effectively than xRAPA (Fig. 2B, top) and that anti-xRAPB coprecipitates Xp54 with xRAPB but much less with xRAPA (Fig. 2B, bottom) .
That xRAPB and p54 make close contacts in vivo can be shown by u.v.-crosslinking of native mRNP particles (Fig. 2C) . Here, both xRAPB and Xp54 are found in complexes with identical mobilities on SDS-PAGE at about 110 kDa, even on using heat-treated pellets which lack YB2 and mRNA and are reacted simultaneously with anti-xRAPB and anti-Xp54. This M r value corresponds well with the interpretation of the formation of heterodimers. These complexes are not affected by ribonuclease treatment after irradiation. In comparison, other mRNP components These results indicate that, during early oogenesis, xRAPB is a natural partner protein for the RNA helicase Xp54, perhaps in selecting mRNAs for early translation.
xRAPB expression complements Xp54 expression in the formation of mRP particles
Once assembled and processed in the nucleus, YB2-and Xp54-bound transcripts become restricted to the cytoplasm (Smillie and Sommerville, 2002) , possibly through anchoring by Scd6 proteins. In order to study the interaction of xRAPB and Xp54 in the presumed cytoplasmic addition of xRAPB to mRNP particles, recombinant forms of the proteins were expressed in vivo after injection into mid-stage, oocytes. T7-tagged Xp54 and myc-epitope-tagged xRAPB, or myc-epitope-tagged xRAPA, were co-expressed from CMV-driven vectors injected directly into oocyte nuclei. This approach has the advantage of accessing the complete, natural pathway of gene expression and therefore is more likely to produce correctly located and functioning proteins (Braddock et al., 1994; Matsumoto et al., 1998) . The compositions of the three recombinant proteins, showing the location of their functional domains, are represented in Fig. 3A .
The relative rates of synthesis of the epitope-tagged proteins were compared with the levels of endogenous proteins by immunoblotting with anti-Xp54 and antixRAPB. It was found that equivalence for both was reached at between 24 h and 48 h post-injection of the relevant vector (Fig. 3B) . Interestingly, for both proteins, as the level of tagged protein increased, the level of endogenous protein appeared to show a corresponding decline, indicating possible homeostatic regulation.
The shorter-term kinetics of co-expression of the recombinant proteins were examined by injecting run-off transcripts (using T3 or T7 polymerase) into the cytoplasms of mid-stage oocytes and sampling for immunoblotting at two-hourly intervals. As can be seen (Fig. 3C) , myc-tagged-xRAPB is detected and accumulated from 4 h post-injection. However, co-expression with T7-tagged-Xp54 leads to earlier detection of both Xp54 and xRAPB (from 2 h). This co-operative effect was then exploited by examining mRNP assembly after nuclear co-injection.
As with co-precipitation of xRAPB and Xp54 from proteins synthesized in vitro (Fig. 2 B) , immunoprecipitation from lysates of oocytes co-expressing myc-tagged xRAPB and T7-tagged Xp54 in vivo, showed co-precipitation using anti-myc epitope, anti-T7 epitope, anti-Xp54 or anti-xRAPB (Fig. 3D) . Non-immune rabbit serum was used as a negative control. The extent of co-precipitation using anti-epitope tags to detect de novo-synthesized myc-xRAPB and T7-Xp54 corresponded well with coprecipitation results using antibodies directed against the native proteins. However, antibodies recognizing Xp54 were more efficient in co-precipitating xRAPB than were the antibodies recognizing xRAPB in co-precipitating Xp54. This would be expected if Xp54 bound to xRAPB constitutes only a sub-fraction of the Xp54 population, assuming that the ectopically expressed proteins behave in a manner similar to their endogenous equivalents.
Stored mRNP particles typically sediment at 30-80S in rate-zonal gradients (Darnbrough and Ford, 1981) . In order to check whether xRAPB is actively incorporated in vivo into newly-synthesized particles, epitope-tagged xRAPB and Xp54 were co-expressed in oocytes and their distribution was analysed after sedimentation in glycerol gradients. Assembly of newly synthesized xRAPB into mRNP particles was found to correspond (in size distribution) to that of newly synthesized Xp54 (Fig. 3E ). Pre-treatment of the oocyte extract with ribonuclease resulted in both xRAPB and Xp54 being resolved in smaller molecular complexes. In contrast, xRAPA, co-expressed with Xp54, appeared to prevent Xp54 from entering into larger mRNP particles, again pointing to the co-operation of xRAPB and Xp54, but a dislocation of xRAPA and Xp54, in early mRNP assembly (Fig. 3F ). It should be noted that immunostaining of all three components can be detected in pelleted post-80S material.
Comparison of the effects of knock-down and over-expression of xRAPA and xRAPB
Previous studies have shown that Xenopus xRAPA (RAP55) represses translation in an in vitro system and also in vivo in oocytes when tethered to a reporter RNA (Tanaka et al., 2006) as has Xp54 (Minshall et al. 2001 (Minshall et al. , 2004 . However, injection of anti-xRAPB IgG into oocytes does not interfere with the formation of masked mRNP particles, whereas injection of anti-Xp54 IgG releases masked reporter transcripts for translation (Braddock et al. 1994) , indicating that xRAPB may not be a translation repressor. In order to explore this possibility, we compared the effects of knockdown and over-expression of xRAPB, xRAPA and Xp54. It has been generally assumed that stored mRNP particles are stable and accumulate until their protein products are required at the appropriate stage of development (reviewed, Weston and Sommerville, 2006) . However, the formation and stability of maternal mRNP appears to involve a much more dynamic scenario. As expected, injection of anti-sense morpholinos (a/sMOs) into the cytoplasm of oocytes expressing recombinant xRAPB and Xp54 from nuclear vectors greatly inhibits their synthesis (Fig. 4A ), but injection of a/sMOs directed against the endogenous mRNAs encoding these protein also results in significant inhibition (Fig. 4B) . No significant MO cross-reactions were detected in comparing all of the targeted proteins. These findings open the possibility of using a/sMOs to examine the effects of depletion of xRAPB, xRAPA and Xp54 on translation rates in injected oocytes. As can be seen (Fig. 4C) , Xp54 a/sMO significantly increases the rate of protein synthesis, whereas xRAPB a/sMO gives slight repression. The effect of xRAPA a/sMO differs little from the effect of a nonspecific control MO. On comparing the spectrum of labelled proteins by SDS-PAGE / autoradiography (Fig. 4D, right panel) it can be seen that the a/sMO treatments result in differences of general signal intensity: there is no evidence for an increase or decrease in the translation of specific proteins. Also, comparison of the radiolabelling with protein staining in individual tracks indicates that the labelled bands do not fully correspond, either in intensity or migration. This reflects oocyte stage-specific translation and differental protein stability. Quantitation of track densities are shown in the accopanying table, again indicating that the most significant deviation from the control is the positive effect of anti-sense of Xp54 mRNA.
Results from the reverse experiment, examining the effect of increased expression of xRAPB, xRAPA and Xp54 on protein synthesis, are shown (Fig. 4E) . Here there is a reversal of outcomes, with over-expression of Xp54 resulting in inhibition of protein synthesis and over-expression of xRAPB in an apparent activation. xRAPA gave no significant difference from the (mock-injected) control. The profiles of newlysynthesized proteins (Fig. 4F ) again showed differences in overall intensity. In the autoradiograph shown, the last two track represents synthesis after co-expression of myc-xRAPB and T7-Xp54, which can be compared with the expression of these proteins individually. In these tracks the over-expressed myc-xRAPB can be discerned at its slower migrating position (white dot and upper arrow), whereas overexpressed T7-Xp54 is obscured in the heavier labelled region of the gel (white dot and lower arrow). Quantitation of track densities confirm a significant inhibition of translation by over-expressed Xp54 and a modest increase in translation of xRAPB (this is with the myc-xRAPB band contribution subtracted from the total). Coexpression with xRAPB with Xp54 leads to moderation of the repressor activity of Xp54 (Fig. 4F) . The least we can conclude is that over-expresion of xRAPB does not inhibit the activity of already translating mRNAs.
xRAPB is associated with translating mRNAs
It might be expected that manipulated changes in translation rate would be reflected in changes in the distribution of mRNP particles, specifically in association with ribosomal components. Rate sedimentation analysis of extracts from mid-stage oocytes containing over-expressed Scd6 proteins show that the distribution of xRAPA remains typical of mRNPs containing endogenous Xp54 and YB2 (Fig. 5A , broken box area), whereas a significant proportion of the myc-xRAPB signal has moved into post-80S fractions not so well represented by Xp54 and YB2 (Fig. 5A, solid box area). The myc-xRAPB signal in faster sedimenting complexes is significantly weaker. The post-80S complexes are disassembled in the presence of EDTA (Fig.   5B ).
Whereas mRNP particles from early-to mid-stage oocytes have been described as forming a heterogeneous size distribution on rate-sedimentation gradients (Darnbrough and Ford, 1981; Cummings and Sommerville, 1988) , native xRAPB is seen to be present in particles with a bimodal distribution, sedimenting in sub-80S and post-120S fractions. This contrasts with Xp54 and YB2, both of which form a continuous distribution across the 80S region (Fig. 5C , broken box area) and indicates that mRNP particles free of xRAPB are present in mid-stage oocytes. On the other hand, the distribution of xRAPB seen here is typical of that of separated stored mRNP and polysomes. Hybridization of gene-specific antisense probes with RNA extracted from the gradient fractions confirms that mRNA not translated during early oogenesis (eg. encoding cyclin B1, Fig. 5C ) is not present in putative polysome fractions but, instead, remains in fractions associated with stored mRNA. On the other hand, earlytranslated mRNA (eg. encoding -tubulin, Fig. 5C ) extends into the polysome region, reflecting the bimodal distribution of xRAPB. Support for these distributions representing a distinction between mRNP storage and translation complexes can be seen from gradients of the same extracts pre-treated with EDTA, which result in the total disruption of post-80S RNP with cyclinB1 mRNA now sedimenting with Xp54 and YB2 at less than 60S and the -tubulin mRNA sedimenting at less than 40S with xRAPB (Fig.5D) . The bimodal distribution of xRAPB is better defined in early-stage oocytes (Fig. 5E ), whereas all post-80S signal is absent from ectopically-expressed xRAPB in late-stage and matured oocytes (Fig. 5F ).
Identification of mRNA classes found in association with xRAPB
Confirmation of direct interaction of early-expressed mRNA species with xRAPB is obtained from RT-PCR of RNA extracted from immunoprecipitated RNP particles (Fig. 6) . In order to standardize precipitation and to minimize potential immunological cross-reaction, both myc-tagged xRAPB and myc-tagged xRAPA were used as the targets for monoclonal anti-myc (cf. Huber and Zhao, 2010). As can be seen (Fig. 6 ), immunoprecipitates (P) from oocytes expressing myc-xRAPB contained mRNA species that are being translated in oocytes (for nuclear actin, -tubulin, EF1a, ribosomal protein L14 and HDACm) but not stored mRNAs that are translated later at oocyte maturation (for cyclin B1 and c-mos), in the egg (for D7) and during early embryogenesis (for somatic YB1 and linker histone H1M). Actively translating mRNAs are not precipitated from oocytes expressing myc-xRAPA, whereas stored mRNAs are precipitated to varying extent. However, this analysis is complicated by instability of some stored mRNAs (eg. encoding cyclin B1 and cmos), but not of translating mRNAs or embryo-expressed mRNAs (eg. for H1M), in myc-xRAPA-expressing oocytes. Additionally, mRNAs that pass through localization pathways in early-to mid-stage oocytes (encoding Xcat2 and Vg1) but are translationally repressed during oogenesis were also immunoprecipitated along with xRAPB.
(All results shown here were generated from the same cDNA templates, the original RNA extracts showing similar amounts of ribosomal RNAs, Fig. 6 .)
Furthermore, incorporation of ectopically-expressed xRAP proteins is to be expected to be more efficient in mRNP complexes with a greater rate of turnover.
Discussion
xRAP is an integral component of poly(A) + RNP in early-stage oocytes
The protein composition of mRNP particles in early-stage oocytes was first defined by Darnbrough and Ford, 1981 . Of the four most abundant proteins associated with poly(A) + RNA, two were characterized later as cold-shock domain Y-box proteins (YB2: Deschamps et al., 1992; Murray et al.,1992) , a third as the DEAD-box RNA helicase Xp54/Dhh1 (Ladomery et al., 1997) and the last as the Scd6 family protein described here as xRAPB. We we define the main features of xRAPB and how they may contribute to differences in function from the other Scd6 protein also present in Xenopus oocytes, xRAPA. xRAPA is the homologue of RAP55 extesively studied in the cells of other vertebrates (Marnef et al., 2009 ).
Immunoblots with anti-Xp52/xRAPB show that the concentration of xRAPB decreases from early oogenesis to full-growth (Fig. 1C,E) , a feature confirmed by immunostaining ovary sections (Fig. 1D) , whereas the concentration of the translation repressor xRAPA increases during oogenesis (Tanaka et al., 2006) . Cross-reacting antibodies clearly show this reciprocal expression pattern (Minshall et al., 2007) .
That xRAPB co-isolates with Xp54, YB2 and CPEB (Minshall et al., 2007) in association with polyadenylated mRNA (Fig. 1E) indicates that this mRNP may be capable of entering the translation pathway. These observations can be compared with the timing of transcriptional activity which starts at maximum in early oocytes and decreases towards full growth and of the steady-state level of mRNA that exists from mid to late oogenesis, maintaining the pool of stored mRNA required for translation during oocyte maturation and early embryogenesis (Sommerville, 1990) .
Thus the availability of xRAPB matches the timing of translation of poly(A) + RNA to maximize oocyte growth, whereas the availability of xRAPA matches the accumulation of stored mRNA.
Interaction of xRAPB with the RNA helicase Xp54
The ability of Xp54 and xRAPB to interact with each other: as in vitro-synthesized proteins (Fig. 2B) ; as native proteins ( Fig. 2C ; Minshall et al., 2009 ): as overexpressed proteins (Fig. 3D) , contrasts with a lack of comparable interaction of Xp54 with xRAPA. Furthermore, co-expression of Xp54 with xRAPB leads to stabilization of xRAPB synthesis (Fig. 3C ) and incorporation of both proteins into mRNP particles with a heterogeneous range of sizes (Fig. 3E) , whereas co-expression xRAPA with Xp54 leads to the incorporation of xRAPA to the exclusion of Xp54, at least in fastsedimenting particles (Fig. 3F) . All of these results confirm Xp54/xRAPB selectivity in the assembly of a specific class of mRNP particles during early-to mid-oogenesis.
During early oogenesis, YB2a/b are much more stable than Xp54 and xRAPB, which have similar turnover rates (Dixon and Ford, 1982) . This reflects the inclusion of YB2a/b in mRNP particles that show continuing translation repression (longer term storage) and the inclusion of Xp54 and xRAPB in translation-ready mRNPs. Here we observed the reduction of YB2a/b in mRNP sedimentation classes that contain mycxRAPB (Fig. 5A ) compared with the maintenance of YB2a/b in sedimentation classes in which native xRAPB is absent (Fig. 5C,E) . Furthermore, the stability of the native Xp54/xRAPB/mRNA complex and removal of YB2a/b in high salt conditions (Fig.   1F ) is consistant with this functional grouping. However, activation of protein synthesis in early-stage oocytes may require dislocation, or conformational change (Minshall et al., 2009 ), of Xp54 from target mRNAs (see Section 4.3). The modification/stimulus required to release Xp54 from mRNP for translation activation is not known, although Xp54 phosphorylation (Sommerville, 1990: Weston and Sommerville 2006) and xRAPB methylation (Matsumoto et al., 2012) can be considered.
Involvement of xRAPB in promoting translation
Evidence presented here, that over-expression of xRAPB can lead to an increase in the rate of amino acid incorporation (Fig. 4E,F) , whereas knock-down suggests a decrease (Fig. 4C,D) , contrasts with the predicted translation repression by Xp54 .
However, ectopic expression of xRAPB tends to neutralize the repressor activity of ectopic Xp54 (Fig. 4F) .
The observation of an increase in the sedimentation rate of myc-xRAPB-containing RNP particles to post-80S fractions (Fig. 4A) is consistent with release of the bound/masked mRNA to enter into a translation initiation complex. Such '90S' particles have been shown previously to contain, in addition to 80S ribosomes and poly(A) + mRNP particles, charged tRNA met (Cummings and Sommerville, 1988) . The transitions from repression to translation potentiation to translation may require sequential removal of masking and repressor proteins. Nevertheless, YB2 orthologues in mammalian cells (YB1/p50) and Chironomus cells (ctYB1) can remain associated with translating mRNAs, albeit with lower stoichiometry (Evdokimova and Ovchinikov, 1998; Soop et al., 2003) . Thus, there is a precedent for core mRNP proteins being carried over into polysomes, as indicated with the detection of overexpressed xRAPB in post-80S (Fig. 5A ) and of native xRAPB in the polysomal region of glycerol gradients (Fig. 5C,E) . What is significant is that the translation repressor Xp54 does not accompany xRAPB in these translocations. Whether xRAPB plays a direct role in translational release is not clear. However, it is interesting to note that the Scd6 paralogue expressed in trypanosomes does not form a complex with the p54/Dhh1 helicase (Cristodero et al., 2014) , although this Scd6 protein, like xRAPA, acts as a translation repressor. In comparison, a fraction of xRAPB from early-to mid-stage oocytes, although apparently free of most of its accompanying Xp54 and YB2a/b, sediments in polysomal regions of glycerol gradients (Fig. 5A,E) . The bimodal distribution formed is characteristic of free and translating mRNP, with all mRNP resolving to the free zone after treatment with EDTA (Fig. 5B) xRAPB is locates only in free (sub-80S) particles (Fig. 5F) 
Identification of catagories of mRNA that bind xRAPB
That the translated mRNAs are indeed associated with xRAPB and not xRAPA is shown by analysis of RT-PCR products of RNA co-immunoprecipitated with xRAPB and xRAPA (Fig. 6) . All of the sequences derived from translating mRNAs were detected in xRAPB co-precipitates and to a much lesser extent in xRAPA coprecipitates (Fig. 6 , right column). Those tested included mRNAs encoding: structual proteins (oocyte-specific -tubulin and nuclear actin); translation components (EF1 and ribosomal protein L14) and stored enzymes (maternal histone deacetylase, HDACm). In addition, however, a category of mRNAs that are not translated in oocytes was also immunoprecipitated along with xRAPB. These are mRNAs localized to the vegetal region in early-stage oocytes: encoding Xcat2/Nanos1 (Lai et al., 2011) and in mid-stage oocytes: encoding Vg1 (Kloc and Etkin, 2005) . The co-precipitation of Vg1 mRNA with xRAPB is consistant with the previous demonstration that xRAPB, together with xRAPC (Fig. 1B) , YB2 and Xp54 can be immunoprecipitated by antibodies recognizing Vg1-localizing proteins (Arthur et al., 2009 ). Here we have
shown that early-localized particles containing Nanos1 mRNA appear also to contain xRAPB. Since Nanos mRNA is specifically translated in the next generation of precursor germ cells, perhaps xRAPB, if still bound, is required for its early activation.
Of the mRNAs not co-precipitated with xRAPB (Fig. 6 , left column), coprecipitation with xRAPA is also absent from those mRNAs not translated until egg formation (D7) or early embryogenesis (somatic YB1 and maternal linker histone H1M). Although the mRNAs to be translated during oocyte maturation (cyclinB1 and c-mos) do appear to have bound xRAPA, the mRNAs themselves appear to be unstable. This may well be due to the over-expression of xRAPA, known to be a component involved with Xp54 in the RNA degradation pathway. This highlights a potential limitation of the use of epitope-tagged proteins as a target for immunoprecipitation: although they present optimum antigenicity, their overexpression may lead to metabolic side-effects.
5 mRNA storage versus translation and turnover
Induction of mRNA degradation by over-expressed RAP55/RAPA has been well documented for a wide range of organisms (Marnef et al., 2009) and in vertebrates appears to be essential for the formation of P-bodies. Xenopus xRAP55 (xRAPA) has been shown to be present in non-defined cytoplasmic foci in oocytes and to locate to P-bodies when expressed in mammalian cells (Tanaka et al., 2006) . 
